You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloid Chimerism

Showing 1 - 25 of 2,662
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)

Recruiting
  • Myeloid Chimerism
  • CliniMACS CD34 Reagent
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Myeloid Malignancy Trial in Detroit (azacitidine)

    Recruiting
    • Myeloid Malignancy
    • Detroit, Michigan
      Henry ford hospital
    Dec 23, 2021

    MDS, Leukemia, Myeloid, Acute Trial in London (DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell

    Unknown status
    • Myelodysplastic Syndromes
    • Leukemia, Myeloid, Acute
    • DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell transplant regardless of peripheral blood CD3 chimerism (including if they have full donor chimerism)
    • DLI will be administered from Month 6 (+/- 20 days) after stem cell transplant according to institutional practice
    • London, United Kingdom
      King's College Hospital NHS Foundation Trust
    Apr 1, 2020

    Adding Azathioprine/Hydroxyurea Preconditioning to

    Recruiting
    • Sickle Cell Disease
    • Preconditioning with azathiprine and hydroxyurea (3 months)
    • Amsterdam, Netherlands
      Amsterdam Medical Centre
    Feb 9, 2022

    Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

    Recruiting
    • Sickle Cell Anemia
    • Beta Thalassemia
    • TBI
    • +6 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Severe Aplastic Anemia Trial (Busulfan, Flu/Cy/ATG or Cy/ATG)

    Not yet recruiting
    • Severe Aplastic Anemia
    • (no location specified)
    Oct 1, 2023

    Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

    Active, not recruiting
    • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023

    Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

    Not yet recruiting
    • Sickle Cell Disease
    • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 4, 2023

    Acute Myeloid Leukemia Trial in Los Angeles, San Francisco (Azacitidine, Tagraxofusp-erzs)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Los Angeles, California
    • +1 more
    Jan 31, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Miltenyi CliniMACS Prodigy ® system
    • (no location specified)
    Mar 23, 2023

    AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • CD33/CLL1 dual CAR-NK cell
    • +5 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Aug 4, 2023

    Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

    Not yet recruiting
    • Acute Myeloid Leukemia in Remission
    • Nantes, Loire Atlantique, France
    • +22 more
    Jun 15, 2023

    AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

    Not yet recruiting
    • AML
    • +5 more
    • Infusion of CD34 selected hematopoietic stem cells
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Sep 14, 2023

    GVHD Trial (Grafalon, Thymoglobulin)

    Not yet recruiting
    • GVHD
    • (no location specified)
    Oct 9, 2023

    AML, Adult Trial in Tianjin (QN-023a, Cyclophosphamid, Fludarabine)

    Recruiting
    • AML, Adult
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 3, 2022

    Allogenic Stem Cell Transplantation Trial (SAR445419)

    Not yet recruiting
    • Allogenic Stem Cell Transplantation
    • (no location specified)
    Feb 13, 2023

    Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Congenital Pure Red Cell Aplasia Trial in United

    Recruiting
    • Bone Marrow Failure Syndrome
    • +6 more
    • Los Angeles, California
    • +23 more
    Aug 15, 2022

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Hyperbaric oxygen
    • Rochester, New York
      Wilmot Cancer Institute, University of Rochester
    May 16, 2022

    AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

    Recruiting
    • AML, Adult
    • CLL1 CAR-NK cell injection
    • Hangzhou, Zhejiang, China
      Clinical research ethics committee of the first affiliated hospi
    Aug 30, 2023

    Myeloid Malignancies Trial in Italy (GvHD prophylaxis)

    Recruiting
    • Myeloid Malignancies
    • GvHD prophylaxis
    • Alessandria, Italy
    • +32 more
    Nov 23, 2022

    AML, Adult Trial in Hangzhou (QN-023a, Cyclophosphamid, Fludarabine)

    Recruiting
    • AML, Adult
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Dec 29, 2022

    Leukemia, Myeloid, MDS Trial in Gainesville (Lenalidomide)

    Terminated
    Has Results
    • Leukemia, Myeloid
    • Myelodysplastic Syndromes
    • Gainesville, Florida
      University of Florida Shands Cancer Center
    Jan 13, 2020

    Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

    Recruiting
    • Leukemia, Myeloid, Acute
    • La Jolla, California
    • +8 more
    Jan 31, 2023

    Severe Combined Immune Deficiency (SCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Enrolling by invitation
    • Severe Combined Immune Deficiency (SCID)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022